Over the past 12 months, 0 insiders at Better Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on BTTX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 23 | Andrew J. ArmaninoDirector | BUY | 274.0K | $0.73 | $200K |
| Jul 27, 23 | Mark A. BermanChief Medical Officer | BUY | 54.8K | $0.73 | $40K |
| Jul 27, 23 | Elder GrangerDirector | BUY | 34.3K | $0.73 | $25K |
| Jul 27, 23 | Frank KarbeChief Executive Officer | BUY | 137.0K | $0.73 | $100K |
| Jul 27, 23 | David P PerryExecutive Chairman | BUY | 1.23M | $0.73 | $900K |
| Jul 27, 23 | Geoffrey M. ParkerDirector | BUY | 685.0K | $0.73 | $500K |
| May 16, 23 | Elder GrangerDirector | BUY | 600 | $0.87 | $522 |
| Apr 10, 23 | Andrew J. ArmaninoDirector | BUY | 303.0K | $0.83 | $252K |
| Apr 10, 23 | David P. Perry 2015 TrustTenPercentOwner | BUY | 3.64M | $0.83 | $3.0M |
| Apr 10, 23 | Frank KarbeSee Remarks | BUY | 242.4K | $0.83 | $201K |
| Apr 10, 23 | Geoffrey M. ParkerDirector | BUY | 303.0K | $0.83 | $252K |
| Sep 16, 22 | David P. Perry 2015 TrustTenPercentOwner | BUY | 39.2K | $2.07 | $81K |
| Sep 15, 22 | David P. Perry 2015 TrustTenPercentOwner | BUY | 10.8K | $1.99 | $22K |
| Sep 15, 22 | Frank KarbeSee Remarks | BUY | 50.0K | $2.09 | $105K |
| Sep 13, 22 | Mark HeinenSee Remarks | BUY | 26.1K | $1.94 | $51K |
| Sep 12, 22 | Mark HeinenSee Remarks | BUY | 23.9K | $1.94 | $46K |
| Jun 24, 22 | Mark HeinenSee Remarks | BUY | 2.3K | $1.75 | $4K |
| Jun 14, 22 | Andrew J. ArmaninoDirector | BUY | 15.0K | $1.39 | $21K |
| Jun 13, 22 | Geoffrey M. ParkerDirector | BUY | 25.0K | $1.45 | $36K |
| Jun 10, 22 | Mark HeinenSee Remarks | BUY | 5.0K | $1.56 | $8K |
| Jun 9, 22 | Andrew J. ArmaninoDirector | BUY | 25.0K | $1.65 | $41K |
| Mar 31, 22 | Mark HeinenSee Remarks | BUY | 5.0K | $1.98 | $10K |
| Mar 31, 22 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As AmendedTenPercentOwner | BUY | 2.5K | $1.97 | $5K |
| Mar 29, 22 | Andrew J. ArmaninoDirector | BUY | 40.0K | $2.14 | $86K |
| Mar 29, 22 | Geoffrey M. ParkerDirector | BUY | 15.0K | $2.15 | $32K |
| Dec 21, 21 | Risa J Lavizzo-moureyDirector | BUY | 10.0K | $4.60 | $46K |
| Dec 20, 21 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As AmendedTenPercentOwner | BUY | 1.0K | $4.60 | $5K |
| Dec 15, 21 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As AmendedTenPercentOwner | BUY | 750 | $4.71 | $4K |
| Dec 15, 21 | Mark HeinenSee Remarks | BUY | 2.3K | $4.70 | $11K |
| Dec 14, 21 | Geoffrey M. ParkerDirector | BUY | 20.0K | $4.94 | $99K |
| Dec 14, 21 | Mark HeinenSee Remarks | BUY | 500 | $5.44 | $3K |
| Dec 13, 21 | Andrew J. ArmaninoDirector | BUY | 21.0K | $5.48 | $115K |
| Dec 13, 21 | Mark HeinenSee Remarks | BUY | 500 | $5.45 | $3K |
| Dec 10, 21 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As AmendedTenPercentOwner | BUY | 1.0K | $5.98 | $6K |
| Dec 3, 21 | Elder GrangerDirector | BUY | 1.0K | $6.66 | $7K |
| Dec 3, 21 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As AmendedTenPercentOwner | BUY | 500 | $6.43 | $3K |
| Dec 2, 21 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As AmendedTenPercentOwner | BUY | 500 | $6.84 | $3K |
| Nov 29, 21 | Andrew J. ArmaninoDirector | BUY | 17.0K | $6.96 | $118K |
| Oct 28, 21 | David P. Perry 2015 TrustTenPercentOwner | BUY | 200.0K | $10.00 | $2.0M |
Over the past 12 months, insiders at Better Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on BTTX, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market BTTX insider purchase in our data was $3.0M by David P. Perry 2015 Trust, TenPercentOwner, filed on Apr 10, 23.
0 different insiders at Better Therapeutics, Inc. filed open-market SEC Form 4 transactions on BTTX over the last 12 months.
InsiderTape plots every BTTX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Better Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →